“…Based on 1, systematic modifications resulted in potent micromolar TGT inhibitors, which also allowed the deciphering of some properties of the binding pocket ( Table 2, 11). 28,30,31 Here we report on the development of a new class of TGT inhibitors, based on scaffold 1 and extended by an imidazole moiety to reveal linbenzoguanine (6-aminoimidazol[4,5-g]quinazolin-8 (7H)-one) 4 (Table 1). This compound, prepared for the first time by Leonard et al 32 , was used as scaffold for substitutions in positions 3 and 4 with various aromatic side-chains to address a hydrophobic cleft formed by Val45, Leu68 and Val282 adjacent to the G 34 binding pocket (Table 2, 5-10).…”